UroGen Pharma URGN Prepaid Forward Obligation
Prepaid Forward Obligation at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept urgn:PrepaidForwardObligation.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's prepaid forward obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's prepaid forward obligation?
- UroGen Pharma (URGN) reported prepaid forward obligation of $128.23M in Q1 2026.
- How has UroGen Pharma's prepaid forward obligation changed year-over-year?
- UroGen Pharma's prepaid forward obligation increased by 4.0% year-over-year, from $123.34M to $128.23M.
- What is the long-term trend for UroGen Pharma's prepaid forward obligation?
- Over 5 years (2020 to 2025), UroGen Pharma's prepaid forward obligation has grown at a 11.2% compound annual growth rate (CAGR), from $75M to $127.28M.
- What does prepaid forward obligation mean?
- This represents a financial arrangement where the company has made an upfront payment for future delivery of goods, services, or financial instruments under a forward contract. It reflects a commitment to future resource allocation and serves as a mechanism to hedge against price volatility or secure supply chain access. Investors monitor this to assess the company's future contractual commitments and the potential impact on future cash flows.